Farmacore is a biotech company that develops and improves value in innovative biotechnological products during all stages, since conception of projects, to supply of active pharmaceutical ingredients (immunobiologicals) specially for the veterinary sector. As a Contract Manufacturing Organization, Farmacore owns technologically advanced Bioprocess Facilities allowing the production of a wide range of plasmid needs, permitting the lowest cost of production and highest product quality, especially in GMP regulated environments. As a Contract Research Organization, the company offers a complete and integrated range of services to pharmaceutical and veterinary companies, and public or private research centres, helping its clients to find practical solutions for their products development in a short time. Bussines Areas and Portfolio Production of active pharmaceutical ingredients GMP Production facility for custom manufacturing solution, capable of satisfying a wide range of plasmid needs, including DNA vaccines. Products Portfolio: DNA plasmids in GMP conditions (DNA-hsp65; DNA-IL-2; DNA-GD-GAG; DNA-GD; DNA-GDE7; DNA-GLEA-2; DNA-EGFRvIII; DNA-MAGE-3); G-CSF, GM-CSF Research, Development and Innovation A state of art CRO providing cost-effectives end to end solutions for novel immune biopharmaceutical products development and bioanalytical characterization. Laboratory for R&D in GLP conditions, with separate areas for microbiology, molecular biology, bioanalytical, cell culture and physicochemical. Areas of Expertise: • Immunobiologicals (prophylactic and therapeutical vaccines, immunomodulators, adjuvants) for tuberculosis, fungal diseases , parasitic diseases (leishmaniasis, schistosomiasis), mastitis • Immunomodulators for allergy , autoimmune disease, cancer • Cell therapy with dendritic cells for cancer Assays Laboratories in GLP conditions able to accomplish different bioanalysis.